{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:33:27Z","timestamp":1784014407226,"version":"3.55.0"},"reference-count":39,"publisher":"National Academy of Sciences","issue":"42","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.pnas.org\/site\/misc\/userlicense.xhtml"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Suomen Akatemia","doi-asserted-by":"publisher","award":["262976"],"award-info":[{"award-number":["262976"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Suomen Akatemia","doi-asserted-by":"publisher","award":["131711"],"award-info":[{"award-number":["131711"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Suomen Akatemia","doi-asserted-by":"publisher","award":["267637"],"award-info":[{"award-number":["267637"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"EC | European Research Council","doi-asserted-by":"publisher","award":["ERC-2010-AdG_268804"],"award-info":[{"award-number":["ERC-2010-AdG_268804"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2015,10,20]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>During the last decades, heart failure has developed into a major burden in the western world, increasingly affecting millions. Cardiac hypertrophy is an adaptive response to myocardial infarction or increased blood pressure, and it often leads to heart failure. Understanding the underlying regulatory processes in the development of pathological hypertrophy is needed for the development of effective therapies. Our results show that the kinase activity of the endothelial bone marrow kinase in chromosome X (Bmx) protein is necessary for the development of pathological cardiac hypertrophy. This finding could provide significant therapeutic applications when specific Bmx kinase inhibitors become available in the clinics.<\/jats:p>","DOI":"10.1073\/pnas.1517810112","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T23:44:54Z","timestamp":1443743094000},"page":"13063-13068","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":41,"title":["Endothelial Bmx tyrosine kinase activity is essential for myocardial hypertrophy and remodeling"],"prefix":"10.1073","volume":"112","author":[{"given":"Tanja","family":"Holopainen","sequence":"first","affiliation":[{"name":"Wihuri Research Institute and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FI-00290 Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"R\u00e4s\u00e4nen","sequence":"additional","affiliation":[{"name":"Wihuri Research Institute and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FI-00290 Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Anisimov","sequence":"additional","affiliation":[{"name":"Wihuri Research Institute and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FI-00290 Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomi","family":"Tuomainen","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, FI-70211 Kuopio, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Wihuri Research Institute and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FI-00290 Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Tvorogov","sequence":"additional","affiliation":[{"name":"Wihuri Research Institute and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FI-00290 Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha J.","family":"Hulmi","sequence":"additional","affiliation":[{"name":"Department of Biology of Physical Activity, University of Jyv\u00e4skyl\u00e4, FI-40700 Jyv\u00e4skyl\u00e4, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif C.","family":"Andersson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Haartman Institute, University of Helsinki, FI-00014 Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Cenni","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Tavi","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, FI-70211 Kuopio, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Mervaala","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, FI-00014 Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riikka","family":"Kivel\u00e4","sequence":"additional","affiliation":[{"name":"Wihuri Research Institute and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FI-00290 Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Alitalo","sequence":"additional","affiliation":[{"name":"Wihuri Research Institute and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FI-00290 Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2015,10]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(14)61889-4","article-title":"The war against heart failure: The Lancet lecture","volume":"385","author":"Braunwald E","year":"2015","unstructured":"E Braunwald, The war against heart failure: The Lancet lecture. Lancet 385, 812\u2013824 (2015).","journal-title":"Lancet"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","article-title":"Angiogenesis and cardiac hypertrophy: Maintenance of cardiac function and causative roles in heart failure","volume":"114","author":"Oka T","year":"2014","unstructured":"T Oka, H Akazawa, AT Naito, I Komuro, Angiogenesis and cardiac hypertrophy: Maintenance of cardiac function and causative roles in heart failure. Circ Res 114, 565\u2013571 (2014).","journal-title":"Circ Res"},{"key":"e_1_3_4_3_2","first-page":"3683","article-title":"BMX, a novel nonreceptor tyrosine kinase gene of the BTK\/ITK\/TEC\/TXK family located in chromosome Xp22.2","volume":"9","author":"Tamagnone L","year":"1994","unstructured":"L Tamagnone, , BMX, a novel nonreceptor tyrosine kinase gene of the BTK\/ITK\/TEC\/TXK family located in chromosome Xp22.2. Oncogene 9, 3683\u20133688 (1994).","journal-title":"Oncogene"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"ra40","DOI":"10.1126\/scisignal.2003936","article-title":"Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinases","volume":"6","author":"Chen S","year":"2013","unstructured":"S Chen, , Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinases. Sci Signal 6, ra40 (2013).","journal-title":"Sci Signal"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1128\/MCB.21.14.4647-4655.2001","article-title":"Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium","volume":"21","author":"Rajantie I","year":"2001","unstructured":"I Rajantie, , Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium. Mol Cell Biol 21, 4647\u20134655 (2001).","journal-title":"Mol Cell Biol"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1158\/0008-5472.CAN-11-1070","article-title":"Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth","volume":"72","author":"Holopainen T","year":"2012","unstructured":"T Holopainen, , Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth. Cancer Res 72, 3512\u20133521 (2012).","journal-title":"Cancer Res"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccr.2011.03.004","article-title":"Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3","volume":"19","author":"Guryanova OA","year":"2011","unstructured":"OA Guryanova, , Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 19, 498\u2013511 (2011).","journal-title":"Cancer Cell"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"e11135","DOI":"10.1371\/journal.pone.0011135","article-title":"Etk\/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: Signaling partners, hierarchy and physiological significance","volume":"5","author":"Cohen I","year":"2010","unstructured":"I Cohen, , Etk\/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: Signaling partners, hierarchy and physiological significance. PLoS One 5, e11135 (2010).","journal-title":"PLoS One"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1091\/mbc.e04-03-0241","article-title":"Bmx tyrosine kinase transgene induces skin hyperplasia, inflammatory angiogenesis, and accelerated wound healing","volume":"15","author":"Paavonen K","year":"2004","unstructured":"K Paavonen, , Bmx tyrosine kinase transgene induces skin hyperplasia, inflammatory angiogenesis, and accelerated wound healing. Mol Biol Cell 15, 4226\u20134233 (2004).","journal-title":"Mol Biol Cell"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.186577","article-title":"Loss of Bmx nonreceptor tyrosine kinase prevents pressure overload-induced cardiac hypertrophy","volume":"103","author":"Mitchell-Jordan SA","year":"2008","unstructured":"SA Mitchell-Jordan, , Loss of Bmx nonreceptor tyrosine kinase prevents pressure overload-induced cardiac hypertrophy. Circ Res 103, 1359\u20131362 (2008).","journal-title":"Circ Res"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.110.957332","article-title":"Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation","volume":"122","author":"Bry M","year":"2010","unstructured":"M Bry, , Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation 122, 1725\u20131733 (2010).","journal-title":"Circulation"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"53H","DOI":"10.1016\/S0002-9149(99)00259-3","article-title":"Role of the renin-angiotensin system in cardiac hypertrophy","volume":"83","author":"Yamazaki T","year":"1999","unstructured":"T Yamazaki, I Komuro, Y Yazaki, Role of the renin-angiotensin system in cardiac hypertrophy. Am J Cardiol 83, 53H\u201357H (1999).","journal-title":"Am J Cardiol"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1038\/sj.onc.1203763","article-title":"The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner","volume":"19","author":"Ekman N","year":"2000","unstructured":"N Ekman, , The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner. Oncogene 19, 4151\u20134158 (2000).","journal-title":"Oncogene"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.4049\/jimmunol.1002813","article-title":"The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner","volume":"186","author":"Gottar-Guillier M","year":"2011","unstructured":"M Gottar-Guillier, , The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner. J Immunol 186, 6014\u20136023 (2011).","journal-title":"J Immunol"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7150\/ijbs.4.184","article-title":"STAT3 activation in pressure-overloaded feline myocardium: Role for integrins and the tyrosine kinase BMX","volume":"4","author":"Willey CD","year":"2008","unstructured":"CD Willey, , STAT3 activation in pressure-overloaded feline myocardium: Role for integrins and the tyrosine kinase BMX. Int J Biol Sci 4, 184\u2013199 (2008).","journal-title":"Int J Biol Sci"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1172\/JCI24682","article-title":"Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure","volume":"115","author":"Shiojima I","year":"2005","unstructured":"I Shiojima, , Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115, 2108\u20132118 (2005).","journal-title":"J Clin Invest"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.yjmcc.2012.09.002","article-title":"Mitochondria in cardiac hypertrophy and heart failure","volume":"55","author":"Rosca MG","year":"2013","unstructured":"MG Rosca, B Tandler, CL Hoppel, Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol 55, 31\u201341 (2013).","journal-title":"J Mol Cell Cardiol"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1128\/MCB.22.21.7512-7523.2002","article-title":"Etk\/Bmx as a tumor necrosis factor receptor type 2-specific kinase: Role in endothelial cell migration and angiogenesis","volume":"22","author":"Pan S","year":"2002","unstructured":"S Pan, , Etk\/Bmx as a tumor necrosis factor receptor type 2-specific kinase: Role in endothelial cell migration and angiogenesis. Mol Cell Biol 22, 7512\u20137523 (2002).","journal-title":"Mol Cell Biol"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.RES.0000338570.27156.84","article-title":"Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy","volume":"103","author":"Kee HJ","year":"2008","unstructured":"HJ Kee, , Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy. Circ Res 103, 1259\u20131269 (2008).","journal-title":"Circ Res"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"Ma XM","year":"2009","unstructured":"XM Ma, J Blenis, Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10, 307\u2013318 (2009).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"e_1_3_4_21_2","first-page":"5377","article-title":"A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation","volume":"126","author":"George AJ","year":"2013","unstructured":"AJ George, , A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation. J Cell Sci 126, 5377\u20135390 (2013).","journal-title":"J Cell Sci"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1182\/blood.V90.11.4341","article-title":"The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta","volume":"90","author":"Saharinen P","year":"1997","unstructured":"P Saharinen, , The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta. Blood 90, 4341\u20134353 (1997).","journal-title":"Blood"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cvr\/cvu034","article-title":"STAT3, a key regulator of cell-to-cell communication in the heart","volume":"102","author":"Haghikia A","year":"2014","unstructured":"A Haghikia, M Ricke-Hoch, B Stapel, I Gorst, D Hilfiker-Kleiner, STAT3, a key regulator of cell-to-cell communication in the heart. Cardiovasc Res 102, 281\u2013289 (2014).","journal-title":"Cardiovasc Res"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/ATVBAHA.113.302878","article-title":"Deficiency of endothelial CXCR4 reduces reendothelialization and enhances neointimal hyperplasia after vascular injury in atherosclerosis-prone mice","volume":"34","author":"Noels H","year":"2014","unstructured":"H Noels, , Deficiency of endothelial CXCR4 reduces reendothelialization and enhances neointimal hyperplasia after vascular injury in atherosclerosis-prone mice. Arterioscler Thromb Vasc Biol 34, 1209\u20131220 (2014).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cvr\/cvr015","article-title":"Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy","volume":"90","author":"Abel ED","year":"2011","unstructured":"ED Abel, T Doenst, Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc Res 90, 234\u2013242 (2011).","journal-title":"Cardiovasc Res"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.yjmcc.2010.12.018","article-title":"Regulation of myocardial growth and death by NADPH oxidase","volume":"50","author":"Maejima Y","year":"2011","unstructured":"Y Maejima, J Kuroda, S Matsushima, T Ago, J Sadoshima, Regulation of myocardial growth and death by NADPH oxidase. J Mol Cell Cardiol 50, 408\u2013416 (2011).","journal-title":"J Mol Cell Cardiol"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.111.243972","article-title":"Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system","volume":"110","author":"Lass\u00e8gue B","year":"2012","unstructured":"B Lass\u00e8gue, A San Mart\u00edn, KK Griendling, Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 110, 1364\u20131390 (2012).","journal-title":"Circ Res"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.111.255216","article-title":"Redox signaling in cardiac physiology and pathology","volume":"111","author":"Burgoyne JR","year":"2012","unstructured":"JR Burgoyne, H Mongue-Din, P Eaton, AM Shah, Redox signaling in cardiac physiology and pathology. Circ Res 111, 1091\u20131106 (2012).","journal-title":"Circ Res"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/ATVBAHA.110.204222","article-title":"Endothelial-specific transgenesis of TNFR2 promotes adaptive arteriogenesis and angiogenesis","volume":"30","author":"Luo Y","year":"2010","unstructured":"Y Luo, , Endothelial-specific transgenesis of TNFR2 promotes adaptive arteriogenesis and angiogenesis. Arterioscler Thromb Vasc Biol 30, 1307\u20131314 (2010).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/HJH.0000000000000358","article-title":"Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension","volume":"33","author":"Gonz\u00e1lez GE","year":"2015","unstructured":"GE Gonz\u00e1lez, , Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension. J Hypertens 33, 144\u2013152 (2015).","journal-title":"J Hypertens"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1016\/j.bmcl.2008.07.062","article-title":"Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase","volume":"18","author":"Hur W","year":"2008","unstructured":"W Hur, , Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase. Bioorg Med Chem Lett 18, 5916\u20135919 (2008).","journal-title":"Bioorg Med Chem Lett"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/15748928113089990043","article-title":"Mini-review: Bmx kinase inhibitors for cancer therapy","volume":"8","author":"Jarboe JS","year":"2013","unstructured":"JS Jarboe, S Dutta, SE Velu, CD Willey, Mini-review: Bmx kinase inhibitors for cancer therapy. Recent Patents Anticancer Drug Discov 8, 228\u2013238 (2013).","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1021\/cb4000629","article-title":"Discovery of a selective irreversible BMX inhibitor for prostate cancer","volume":"8","author":"Liu F","year":"2013","unstructured":"F Liu, , Discovery of a selective irreversible BMX inhibitor for prostate cancer. ACS Chem Biol 8, 1423\u20131428 (2013).","journal-title":"ACS Chem Biol"},{"key":"e_1_3_4_34_2","unstructured":"T O\u2019Connell Y Ni Isolation of Adult Mouse Cardiac Myocytes from One Heart . AfCS Procedure Protocol ID PP00000125. Available at www.signaling-gateway.org\/data\/cgi-bin\/ProtocolFile.cgi?pid=PP00000125. Accessed September 22 2015. (2002)."},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00109-006-0097-6","article-title":"Quantitative real-time RT-PCR data analysis: Current concepts and the novel \u201cgene expression\u2019s CT difference\u201d formula","volume":"84","author":"Schefe JH","year":"2006","unstructured":"JH Schefe, KE Lehmann, IR Buschmann, T Unger, H Funke-Kaiser, Quantitative real-time RT-PCR data analysis: Current concepts and the novel \u201cgene expression\u2019s CT difference\u201d formula. J Mol Med (Berl) 84, 901\u2013910 (2006).","journal-title":"J Mol Med (Berl)"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang W","year":"2009","unstructured":"W Huang, BT Sherman, RA Lempicki, Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37, 1\u201313 (2009).","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang W","year":"2009","unstructured":"W Huang, BT Sherman, RA Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44\u201357 (2009).","journal-title":"Nat Protoc"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian A","year":"2005","unstructured":"A Subramanian, , Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102, 15545\u201315550 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha VK","year":"2003","unstructured":"VK Mootha, , PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267\u2013273 (2003).","journal-title":"Nat Genet"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1517810112","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1517810112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T09:01:45Z","timestamp":1654592505000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1517810112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":39,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2015,10,20]]}},"alternative-id":["10.1073\/pnas.1517810112"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1517810112","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"2015-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}